JUNTEN BIO, focusing on the human immune system and taking “From life to drug creation” as its motto,
carries out R&D on cellular medicines using regenerative medicine technologies for diseases that cannot be
treated with currently available drugs.
We aim to be a society where people can improve their quality of life and live a healthy life.
On the basis of Juntendo University’s research seeds, we are tackling
the development of cellular medicines that induce immune tolerance,
by means of antigen-selective immunosuppressive effect.
In order to eliminate side effects due to immunosuppressant
administration after organ transplantation, and to contribute
reducing medical costs, we aim to
develop the world’s first
revolutionary cellular medicine, and thus to achieve practical treatment
in this area.
Cell therapy that achieves specific immunosuppression in relation to
living-donor liver transplant, using inducible inhibitory T-cells.
*Our aim is to expand the indications in the future, such for kidney transplants
and late-phase patients (i.e. transplantation already completed).
Otemachi Nomura Building 20F,
2-1-1 Otemachi, Chiyoda-ku, Tokyo, 100-0004
Inducible inhibitory T-cells (JB-101) jointly developed with Juntendo University were designated as a product to be included in the Ministry of Health, Labour and Welfare’s system of expedited reviews aiming to make Japan the world’s leader in the application of innovative medicine.
An investigator-initiated clinical study on JB-101 for living-donor liver transplants was started with collaborative researchers at Juntendo University.
For the purpose of sound corporate management in accordance with both in-house rules and public regulations,
JUNTEN BIO has established a Compliance Committee and a section responsible for internal control.
All company employees are to be informed and educated to make them fully aware of the rules and structures that must be
complied with or used. In addition, an appropriate supervisory system is established for all administrative processes so that the
tasks are performed appropriately and efficiently with the aim of meeting JUNTEN BIO’s management targets.